Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127,712 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15-mg Tylerdipine Tablet in Healthy Chinese Male Volunteers.
Wang L, Xie L, Zhou S, Wang Y, Chen J, Zhou Y, Liu Y, Zhang H, Tao M, Ou N, Shao F. Wang L, et al. Among authors: chen j. Clin Pharmacol Drug Dev. 2019 Jan;8(1):126-132. doi: 10.1002/cpdd.622. Epub 2018 Oct 10. Clin Pharmacol Drug Dev. 2019. PMID: 30303628 Clinical Trial.
Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study.
Zheng S, Shao F, Ding Y, Fu Z, Fu Q, Ding S, Xie L, Chen J, Zhou S, Zhang H, Zhou H, Chen Y, Sun C, Zhu J, Zheng X, Yang T. Zheng S, et al. Among authors: chen j, chen y. Clin Drug Investig. 2020 Dec;40(12):1155-1166. doi: 10.1007/s40261-020-00971-x. Epub 2020 Oct 30. Clin Drug Investig. 2020. PMID: 33125674 Clinical Trial.
Tolerability, safety, pharmacokinetics and pharmacodynamics of SHR0534, a potent G protein-coupled receptor 40 (GPR40) agonist, at single- and multiple-ascending oral doses in healthy Chinese subjects.
Zhao Y, Xie L, Ou N, Wu J, Zhang H, Zhou S, Liu Y, Chen J, Wang L, Wang L, Wang J, Shao F. Zhao Y, et al. Among authors: chen j. Xenobiotica. 2021 Mar;51(3):297-306. doi: 10.1080/00498254.2020.1864510. Epub 2020 Dec 28. Xenobiotica. 2021. PMID: 33331206 Clinical Trial.
First-in-Human, Single-Ascending Dose and Food Effect Studies to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Cetagliptin, a Dipeptidyl Peptidase-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus.
Wang L, Lu J, Zhou S, Zhao Y, Xie L, Zhou C, Chen J, Ding S, Xie D, Ding J, Yu Q, Shen H, Hao G, Shao F. Wang L, et al. Among authors: chen j. Clin Drug Investig. 2021 Nov;41(11):999-1010. doi: 10.1007/s40261-021-01088-5. Epub 2021 Oct 16. Clin Drug Investig. 2021. PMID: 34655432 Clinical Trial.
Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW, Sun LN, Li YQ, Yu L, Zhang HW, Wang MF, Yu LY, Yuan ZQ, Xie LJ, Chen J, Meng L, Zhang XH, Wang YQ. Jiao HW, et al. Among authors: chen j. Eur J Clin Pharmacol. 2018 Mar;74(3):257-265. doi: 10.1007/s00228-017-2372-6. Epub 2017 Nov 22. Eur J Clin Pharmacol. 2018. PMID: 29167917 Clinical Trial.
127,712 results
You have reached the last available page of results. Please see the User Guide for more information.